Abstract
Cancer cells are able to elaborate enzymatic mechanisms allowing tumors to resist or escape imune rejection. Among the enzymes involved, indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme that initiates the first and rate-limiting step of tryptophan breakdown along the kynurenine pathway, has emerged as a promising molecular target for the development of new immunotherapeutic anticancer agents. This review summarizes the synthesis and IDO activities of the different classes of marine and other inhibitors reported so far.
Keywords: Indoleamine 2, 3-dioxygenase, IDO inhibitors, marine natural compounds.
Mini-Reviews in Medicinal Chemistry
Title:Marine Natural Products and Other Derivatives as Potent Indoleamine 2,3-Dioxygenase Inhibitors
Volume: 12 Issue: 10
Author(s): Evelyne Delfourne
Affiliation:
Keywords: Indoleamine 2, 3-dioxygenase, IDO inhibitors, marine natural compounds.
Abstract: Cancer cells are able to elaborate enzymatic mechanisms allowing tumors to resist or escape imune rejection. Among the enzymes involved, indoleamine 2,3-dioxygenase (IDO), an intracellular enzyme that initiates the first and rate-limiting step of tryptophan breakdown along the kynurenine pathway, has emerged as a promising molecular target for the development of new immunotherapeutic anticancer agents. This review summarizes the synthesis and IDO activities of the different classes of marine and other inhibitors reported so far.
Export Options
About this article
Cite this article as:
Delfourne Evelyne, Marine Natural Products and Other Derivatives as Potent Indoleamine 2,3-Dioxygenase Inhibitors, Mini-Reviews in Medicinal Chemistry 2012; 12 (10) . https://dx.doi.org/10.2174/138955712802762374
DOI https://dx.doi.org/10.2174/138955712802762374 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Angiogenesis in Rheumatoid Arthritis
Current Rheumatology Reviews An Overview on Bacteriophages: A Natural Nanostructured Antibacterial Agent
Current Drug Delivery The Chemical Biology of Immunophilin Ligands
Current Medicinal Chemistry Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging
Current Nanoscience The IFN-λ Family (IL-28/29)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin
Current Drug Delivery Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research Drug Delivery to the Back of the Eye Following Topical Administration: An Update on Research and Patenting Activity
Recent Patents on Drug Delivery & Formulation New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Biologically Active Natural Products of the Genus Callicarpa
Current Bioactive Compounds Non-coding RNAs in Exosomes: New Players in Cancer Biology
Current Genomics Overcoming Drug Resistance and Treating Advanced Prostate Cancer
Current Drug Targets Immunological Mechanism and Clinical Application of PAMP Adjuvants
Recent Patents on Anti-Cancer Drug Discovery Editorial (Thematic Issue: Personalized Cancer Treatment)
Current Molecular Pharmacology Recent Developments in Targeting Breast Cancer Stem Cells
Recent Patents on Regenerative Medicine Clinical Signs, Prevention and Treatment of Viral Infections in Infants
Infectious Disorders - Drug Targets Morpho-Functional Features of In-Vitro Cell Death Induced by Physical Agents
Current Pharmaceutical Design Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents
Current Topics in Medicinal Chemistry